Fc-VWF-XTEN
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assay of Efanesoctocog Alfa in 200 Centres: Data from Collaborative NEQAS BC (United Kingdom) and ECAT (Netherlands) Exercise Autumn 2024.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 18, 2025
The Laboratory Monitoring of Altuvoct (Efanesoctocog Alfa): Recommendations From the Laboratory Working Party of the United Kingdom Haemophilia Centres Doctor's Organisation.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 16, 2025
Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?
Journal: Expert opinion on pharmacotherapy
Published: August 19, 2024
Practical challenges associated with efanesoctocog alfa (ALTUVIIIO) prophylaxis in a 19-month-old male with severe hemophilia A.
Journal: Pediatric blood & cancer
Published: March 14, 2024
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.
Journal: Haematologica
Published: December 04, 2023
Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A.
Journal: Expert review of hematology
Published: June 08, 2023
Altuviiio - a longer-acting factor VIII product for hemophilia A.
Journal: The Medical letter on drugs and therapeutics
Published: May 08, 2023
Showing 1-8 of 8
Last Updated: 02/24/2026